Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial

BACKGROUND: The delivery of antipseudomonal antibiotics by inhalation to Pseudomonas aeruginosa-infected subjects with non-cystic fibrosis (CF) bronchiectasis is a logical extension of treatment strategies successfully developed in CF bronchiectasis. Dual release ciprofloxacin for inhalation (DRCFI)...

詳細記述

保存先:
書誌詳細
出版年:Thorax
主要な著者: Serisier, David J, Bilton, Diana, De Soyza, Anthony, Thompson, Philip J, Kolbe, John, Greville, Hugh W, Cipolla, David, Bruinenberg, Paul, Gonda, Igor
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Publishing Group 2013
主題:
Bronchiectasis
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4770250/
https://ncbi.nlm.nih.gov/pubmed/23681906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2013-203207
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料